Blue Cross Plans Will Back Nonprofit Drug Maker’s Cheaper Insulin

Blue Cross and Blue Shield health insurance companies say they will join nonprofit drug maker Civica Rx’s effort to make and sell cheaper versions of insulin at more than $30 per vial.